isoxazoles has been researched along with Peritoneal Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Im, DS; Ishii, S; Kimura, T; Komachi, M; Mogi, C; Ohta, H; Okajima, F; Sato, K; Takeyoshi, I; Tobo, M; Tomura, H; Yamada, T; Yanagida, K | 1 |
| Bleichrodt, RP; Boerman, OC; Goldenberg, DM; Hendriks, T; Koppe, MJ; Oyen, WJ; Verhofstad, AA | 1 |
| Isoe, T; Miura, T; Nakamura, K; Shibuya, M; Taguchi, E | 1 |
| Borden, EC; Falkson, G; Simson, IW; Vorobiof, DA | 1 |
4 other study(ies) available for isoxazoles and Peritoneal Neoplasms
| Article | Year |
|---|---|
Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
Topics: Animals; Ascites; Cell Line, Tumor; Cell Movement; Humans; Isoxazoles; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Peritoneal Neoplasms; Propionates; Receptors, Lysophosphatidic Acid; Xenograft Model Antitumor Assays | 2012 |
Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
Topics: Animals; Antibodies, Monoclonal; Carcinoma; Colonic Neoplasms; Cyclooxygenase Inhibitors; Iodine Radioisotopes; Isoxazoles; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Peritoneal Neoplasms; Radioimmunotherapy; Survival; Tissue Distribution; Transplantation, Heterologous | 2006 |
Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.
Topics: Animals; Antineoplastic Agents; Ascites; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Humans; Isoxazoles; Neovascularization, Pathologic; Peritoneal Neoplasms; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Inbred F344; Receptors, Vascular Endothelial Growth Factor | 2008 |
Phase II trial of acivicin in malignant mesothelioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Isoxazoles; Male; Mesothelioma; Middle Aged; Oxazoles; Peritoneal Neoplasms; Pleural Neoplasms | 1987 |